Ophthalmics, Inc. Tracks Pharmaceuticals to DSCSA Requirements A - TulsaCW.com: TV To Talk About | The Tulsa CW

Ophthalmics, Inc. Tracks Pharmaceuticals to DSCSA Requirements Ahead of Schedule


San Antonio, FL, November 08, 2019 --(PR.com)-- Ophthalmics, Inc., a leading wholesale supplier of eye care supplies for ophthalmic and optometric practices, is proud to announce that they are fully compliant with pharmaceutical tracking as required by the new Drug Supply Chain Securities Act (DSCSA) ahead of the November 27, 2019 deadline.

Every pharmaceutical unit sold in the USA now has a serial number. It allows each drug to be tracked from manufacturer to end user. Distributors of pharmaceuticals must be able to track each unit sold and keep a record of the chain of distribution. The deadline for compliance is November 27, 2019.

CIO Tom Fox states, “We looked into purchasing a service to handle DSCSA tracking requirements, but it was not cost effective. So, we created our own proprietary software system to be able to track each incoming and outgoing shipment of every pharmaceutical we sell. This allows us to keep our overhead costs down. Lower overhead costs mean lower prices for our customers.”

Ophthalmics, Inc. has combined low prices and highly trained customer service staff with technology enhancements like rewards points for order discounts, live inventory data, and up to date order tracking, to give customers the tools they need to be successful. Customers are encouraged to visit Ophthalmics, Inc.’s website at www.shophthalmics.com to see why they are quickly becoming the top choice for eye care professionals in the US.

About Ophthalmics, Inc.
Founded in 2018, Ophthalmics, Inc. is a leading supplier of eye care supplies to ophthalmic and optometric practices. Its mission is to be the premier wholesale distributor of eye care supplies in the USA. By using state of the art technology and aligning with the best manufacturers, Ophthalmics, Inc. is creating a marketplace that is second to none.

Contact Information:
Ophthalmics, Inc.
Tom Gosselin
Contact via Email

Read the full story here: https://www.pr.com/press-release/798991

Press Release Distributed by PR.com

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklymedia.com

Powered by Frankly
All content © Copyright 2000 - 2020 KQCW. All Rights Reserved.
For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.